Evidence map›Paper›PMID 38643439›Full record

ArticleJournal of thrombosis and thrombolysis2024

Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide.

Marcin Sadowski, Michał Ząbczyk, Anetta Undas

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thrombosis and thrombolysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Marcin SadowskiCollegium Medicum, Jan Kochanowski University, Kielce, Poland.
Michał ZąbczykDepartment of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Anetta UndasDepartment of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland. mmundas@cyf-kr.edu.pl.ORCID http://orcid.org/0000-0002-0667-8109
Jagiellonian University · PLJan Kochanowski University · PL

Funding

Wydział Lekarski, Uniwersytet Jagielloński Collegium Medicum N41/DBS/000516
6 · The paper itself

Abstract

It is unknown whether elevated gut-derived serum lipopolysaccharide (LPS) can affect thrombin generation, fibrinolysis, and fibrin clot properties in atrial fibrillation (AF). We aimed to evaluate associations of circulating LPS with prothrombotic markers in AF patients. A total of 157 (women, 57.3%) ambulatory anticoagulant-naïve AF patients aged from 42 to 86 years were recruited. Clinical data together with serum LPS, inflammation, endothelial injury, coagulation and fibrinolysis markers, including fibrin clot permeability (K

Indexed as

Atrial FibrillationFibrinolysisLipopolysaccharidesAdultAgedAged, 80 and overBiomarkersFemaleFibrin Clot Lysis TimeHumansMaleMiddle AgedPlasminogen Activator Inhibitor 1BiomarkersLipopolysaccharidesPlasminogen Activator Inhibitor 1Atrial fibrillationClot propertiesFibrinolysisGut microbiotaLipopolysaccharide

Identifiers

PMID38643439
PMCPMC11233339
OpenAlexW4394984079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.